trending Market Intelligence /marketintelligence/en/news-insights/trending/kzkQKYitNvP9OHhQH3Jr1Q2 content esgSubNav
In This List

Allergan's topical cream for facial redness gets thumbs up from US FDA

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


Allergan's topical cream for facial redness gets thumbs up from US FDA

The U.S. FDA approved Allergan PLC's Rhofade cream for the treatment of persistent facial redness in adults with rosacea, a common long-term skin disease.

Rhofade will be commercially available in the U.S. starting in May.